Barbara Marie O'Brien, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Prenatal Diagnosis | 10 | 2019 | 1179 | 1.760 |
Why?
|
| Fetofetal Transfusion | 10 | 2015 | 117 | 1.150 |
Why?
|
| Genetic Counseling | 3 | 2018 | 578 | 1.050 |
Why?
|
| Fetal Diseases | 5 | 2014 | 900 | 0.990 |
Why?
|
| Aneuploidy | 5 | 2017 | 479 | 0.780 |
Why?
|
| DNA | 7 | 2017 | 7097 | 0.720 |
Why?
|
| Fetoscopy | 7 | 2014 | 115 | 0.710 |
Why?
|
| Rh Isoimmunization | 1 | 2018 | 23 | 0.690 |
Why?
|
| Genetic Diseases, Inborn | 2 | 2018 | 601 | 0.650 |
Why?
|
| Genetics | 1 | 2018 | 125 | 0.650 |
Why?
|
| Nuchal Translucency Measurement | 1 | 2017 | 54 | 0.610 |
Why?
|
| Laser Therapy | 8 | 2014 | 1070 | 0.600 |
Why?
|
| Genetic Testing | 7 | 2018 | 3350 | 0.580 |
Why?
|
| Certification | 1 | 2018 | 412 | 0.530 |
Why?
|
| Pamphlets | 2 | 2014 | 74 | 0.520 |
Why?
|
| Dendrites | 1 | 2017 | 543 | 0.510 |
Why?
|
| Nociceptors | 1 | 2017 | 441 | 0.500 |
Why?
|
| HLA Antigens | 1 | 2018 | 1545 | 0.430 |
Why?
|
| Pregnancy | 31 | 2019 | 27398 | 0.430 |
Why?
|
| Erythroblastosis, Fetal | 1 | 2011 | 43 | 0.420 |
Why?
|
| Quadruplets | 1 | 2010 | 9 | 0.400 |
Why?
|
| Foodborne Diseases | 1 | 2010 | 41 | 0.400 |
Why?
|
| Thrombocytopenia | 1 | 2018 | 1142 | 0.390 |
Why?
|
| Blood Component Removal | 1 | 2011 | 117 | 0.380 |
Why?
|
| Transplantation | 1 | 2010 | 224 | 0.340 |
Why?
|
| ABO Blood-Group System | 1 | 2011 | 361 | 0.340 |
Why?
|
| Education, Nursing, Baccalaureate | 1 | 2008 | 22 | 0.340 |
Why?
|
| Placenta | 6 | 2019 | 1538 | 0.330 |
Why?
|
| Twins | 1 | 2009 | 354 | 0.320 |
Why?
|
| Selection Bias | 1 | 2008 | 365 | 0.290 |
Why?
|
| Trisomy | 4 | 2017 | 259 | 0.280 |
Why?
|
| Postpartum Hemorrhage | 1 | 2006 | 242 | 0.230 |
Why?
|
| Pregnancy Trimester, Second | 3 | 2017 | 712 | 0.230 |
Why?
|
| Clinical Competence | 1 | 2018 | 4630 | 0.220 |
Why?
|
| Erythrocytes | 1 | 2011 | 2410 | 0.210 |
Why?
|
| Chromosome Disorders | 3 | 2014 | 496 | 0.200 |
Why?
|
| Fetus | 6 | 2019 | 1853 | 0.190 |
Why?
|
| Diseases in Twins | 2 | 2015 | 463 | 0.190 |
Why?
|
| Ultrasonography, Prenatal | 5 | 2015 | 1600 | 0.180 |
Why?
|
| Informed Consent | 2 | 2017 | 963 | 0.180 |
Why?
|
| Pregnancy Outcome | 6 | 2019 | 2719 | 0.180 |
Why?
|
| Oxytocics | 2 | 2011 | 58 | 0.170 |
Why?
|
| Antigens, Human Platelet | 1 | 2018 | 42 | 0.170 |
Why?
|
| Rh-Hr Blood-Group System | 1 | 2018 | 59 | 0.170 |
Why?
|
| Relaxin | 1 | 2017 | 31 | 0.160 |
Why?
|
| Health Promotion | 1 | 2010 | 2212 | 0.160 |
Why?
|
| Pregnancy Complications | 4 | 2014 | 2843 | 0.160 |
Why?
|
| Data Interpretation, Statistical | 1 | 2008 | 2729 | 0.160 |
Why?
|
| Peripartum Period | 1 | 2018 | 111 | 0.160 |
Why?
|
| Hong Kong | 1 | 2017 | 158 | 0.150 |
Why?
|
| Placenta Diseases | 1 | 2019 | 188 | 0.150 |
Why?
|
| Fetal Membranes, Premature Rupture | 2 | 2014 | 134 | 0.150 |
Why?
|
| Regulatory Elements, Transcriptional | 1 | 2017 | 183 | 0.150 |
Why?
|
| Karyotyping | 4 | 2014 | 1266 | 0.150 |
Why?
|
| Female | 39 | 2019 | 377204 | 0.150 |
Why?
|
| Health Knowledge, Attitudes, Practice | 3 | 2018 | 3959 | 0.150 |
Why?
|
| Fetal Death | 3 | 2019 | 456 | 0.140 |
Why?
|
| Early Detection of Cancer | 3 | 2015 | 2939 | 0.140 |
Why?
|
| Platelet Transfusion | 1 | 2018 | 285 | 0.140 |
Why?
|
| Zinc Fingers | 1 | 2017 | 595 | 0.140 |
Why?
|
| Embryo Transfer | 1 | 2019 | 505 | 0.130 |
Why?
|
| Cri-du-Chat Syndrome | 1 | 2014 | 13 | 0.130 |
Why?
|
| Oxytocin | 2 | 2011 | 372 | 0.130 |
Why?
|
| Mosaicism | 2 | 2014 | 447 | 0.130 |
Why?
|
| Hypertension, Pregnancy-Induced | 1 | 2019 | 421 | 0.120 |
Why?
|
| Prader-Willi Syndrome | 1 | 2014 | 69 | 0.120 |
Why?
|
| Chromosomes, Human, Pair 22 | 1 | 2014 | 348 | 0.120 |
Why?
|
| Sensory Receptor Cells | 1 | 2017 | 445 | 0.120 |
Why?
|
| Humans | 46 | 2019 | 715777 | 0.120 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 2014 | 340 | 0.110 |
Why?
|
| Pregnant Women | 1 | 2017 | 504 | 0.110 |
Why?
|
| Angelman Syndrome | 1 | 2014 | 123 | 0.110 |
Why?
|
| Twins, Monozygotic | 1 | 2014 | 470 | 0.110 |
Why?
|
| Sigmoidoscopy | 1 | 2012 | 155 | 0.110 |
Why?
|
| Quality Control | 1 | 2015 | 867 | 0.110 |
Why?
|
| Ethics, Medical | 1 | 2017 | 805 | 0.110 |
Why?
|
| Craniopharyngioma | 1 | 2014 | 278 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2014 | 678 | 0.110 |
Why?
|
| Prenatal Care | 2 | 2017 | 1040 | 0.100 |
Why?
|
| Delivery, Obstetric | 2 | 2011 | 907 | 0.100 |
Why?
|
| Midwifery | 1 | 2012 | 122 | 0.100 |
Why?
|
| Mass Screening | 4 | 2017 | 5209 | 0.100 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2017 | 857 | 0.100 |
Why?
|
| United States Department of Agriculture | 1 | 2010 | 45 | 0.100 |
Why?
|
| Choice Behavior | 1 | 2017 | 794 | 0.100 |
Why?
|
| Hemoglobinometry | 1 | 2010 | 35 | 0.100 |
Why?
|
| Misoprostol | 1 | 2011 | 84 | 0.100 |
Why?
|
| Food Handling | 1 | 2010 | 137 | 0.100 |
Why?
|
| Pitch Perception | 1 | 2011 | 110 | 0.100 |
Why?
|
| Stillbirth | 1 | 2012 | 315 | 0.100 |
Why?
|
| Down Syndrome | 2 | 2017 | 806 | 0.090 |
Why?
|
| Focus Groups | 2 | 2014 | 1264 | 0.090 |
Why?
|
| Ischemia | 1 | 2019 | 1906 | 0.090 |
Why?
|
| Geniculate Bodies | 1 | 2011 | 172 | 0.090 |
Why?
|
| Spectrophotometry | 1 | 2010 | 372 | 0.090 |
Why?
|
| Tachycardia, Ectopic Atrial | 1 | 2009 | 54 | 0.090 |
Why?
|
| Chromosome Deletion | 1 | 2014 | 1373 | 0.090 |
Why?
|
| Digital Rectal Examination | 1 | 2009 | 43 | 0.090 |
Why?
|
| Reproductive Techniques, Assisted | 1 | 2013 | 458 | 0.090 |
Why?
|
| Auditory Pathways | 1 | 2011 | 227 | 0.090 |
Why?
|
| Pre-Eclampsia | 1 | 2017 | 1108 | 0.090 |
Why?
|
| Blood Donors | 1 | 2011 | 354 | 0.090 |
Why?
|
| Congenital Abnormalities | 2 | 2015 | 696 | 0.090 |
Why?
|
| Chromosome Aberrations | 2 | 2012 | 1808 | 0.090 |
Why?
|
| Caenorhabditis elegans | 1 | 2017 | 1410 | 0.090 |
Why?
|
| Nursing Research | 1 | 2008 | 74 | 0.080 |
Why?
|
| Laser Coagulation | 1 | 2010 | 327 | 0.080 |
Why?
|
| Audiovisual Aids | 1 | 2008 | 92 | 0.080 |
Why?
|
| Auditory Cortex | 1 | 2011 | 326 | 0.080 |
Why?
|
| Adult | 16 | 2019 | 212266 | 0.080 |
Why?
|
| Gynecology | 1 | 2012 | 475 | 0.080 |
Why?
|
| Maternal Health Services | 1 | 2012 | 438 | 0.080 |
Why?
|
| Ergonovine | 1 | 2006 | 16 | 0.080 |
Why?
|
| Labor Stage, Third | 1 | 2006 | 6 | 0.080 |
Why?
|
| Anesthesia, General | 1 | 2014 | 1102 | 0.080 |
Why?
|
| Amnion | 1 | 2008 | 206 | 0.080 |
Why?
|
| DNA Fragmentation | 1 | 2007 | 249 | 0.070 |
Why?
|
| Erythropoietin | 1 | 2011 | 734 | 0.070 |
Why?
|
| Interprofessional Relations | 1 | 2012 | 1019 | 0.070 |
Why?
|
| Colorectal Neoplasms | 3 | 2015 | 6592 | 0.070 |
Why?
|
| Twinning, Monozygotic | 2 | 2015 | 17 | 0.070 |
Why?
|
| Obstetrics | 1 | 2012 | 632 | 0.070 |
Why?
|
| Amniotic Fluid | 1 | 2007 | 361 | 0.070 |
Why?
|
| Chorion | 2 | 2015 | 116 | 0.070 |
Why?
|
| Prostaglandins | 1 | 2006 | 429 | 0.070 |
Why?
|
| Infant, Newborn | 6 | 2019 | 24798 | 0.070 |
Why?
|
| Problem-Based Learning | 1 | 2008 | 341 | 0.060 |
Why?
|
| Patient Education as Topic | 1 | 2014 | 2330 | 0.060 |
Why?
|
| Population Surveillance | 1 | 2015 | 2650 | 0.060 |
Why?
|
| Quality Assurance, Health Care | 1 | 2015 | 2260 | 0.060 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2012 | 4040 | 0.060 |
Why?
|
| Interviews as Topic | 1 | 2010 | 2596 | 0.060 |
Why?
|
| Abnormalities, Multiple | 2 | 2009 | 1380 | 0.060 |
Why?
|
| Antibodies | 1 | 2011 | 2432 | 0.060 |
Why?
|
| Prostatic Neoplasms | 3 | 2015 | 10605 | 0.050 |
Why?
|
| Ovarian Neoplasms | 2 | 2015 | 4751 | 0.050 |
Why?
|
| Membrane Proteins | 1 | 2017 | 8047 | 0.050 |
Why?
|
| Multicenter Studies as Topic | 2 | 2015 | 1525 | 0.050 |
Why?
|
| DNA-Binding Proteins | 1 | 2017 | 9730 | 0.050 |
Why?
|
| Prostate-Specific Antigen | 1 | 2009 | 2278 | 0.050 |
Why?
|
| Endoscopy | 1 | 2009 | 1756 | 0.050 |
Why?
|
| Fatal Outcome | 2 | 2014 | 1879 | 0.040 |
Why?
|
| Immunoglobulin G | 1 | 2011 | 4492 | 0.040 |
Why?
|
| Gene Expression Regulation | 1 | 2017 | 12305 | 0.040 |
Why?
|
| Freezing | 1 | 2019 | 297 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2014 | 14902 | 0.040 |
Why?
|
| Young Adult | 4 | 2018 | 56226 | 0.040 |
Why?
|
| Premature Birth | 1 | 2010 | 1560 | 0.040 |
Why?
|
| Transcription Factors | 1 | 2017 | 11953 | 0.040 |
Why?
|
| Alzheimer Disease | 1 | 2017 | 7259 | 0.040 |
Why?
|
| Inhibins | 1 | 2017 | 226 | 0.040 |
Why?
|
| Microsurgery | 2 | 1980 | 811 | 0.040 |
Why?
|
| Cell-Free System | 1 | 2017 | 359 | 0.040 |
Why?
|
| Stem Cell Transplantation | 1 | 2005 | 1639 | 0.040 |
Why?
|
| Communication | 1 | 2010 | 3516 | 0.040 |
Why?
|
| Pregnancy Rate | 1 | 2019 | 599 | 0.040 |
Why?
|
| Blastocyst | 1 | 2019 | 433 | 0.040 |
Why?
|
| United States | 6 | 2015 | 67905 | 0.040 |
Why?
|
| Drug Therapy, Combination | 1 | 2006 | 6552 | 0.030 |
Why?
|
| Germany | 1 | 2017 | 836 | 0.030 |
Why?
|
| Evidence-Based Medicine | 1 | 2008 | 3683 | 0.030 |
Why?
|
| Live Birth | 1 | 2019 | 463 | 0.030 |
Why?
|
| Knowledge | 1 | 2017 | 161 | 0.030 |
Why?
|
| Cryopreservation | 1 | 2019 | 631 | 0.030 |
Why?
|
| Polycythemia | 1 | 2015 | 117 | 0.030 |
Why?
|
| Fetal Therapies | 1 | 2015 | 103 | 0.030 |
Why?
|
| Risk Factors | 4 | 2019 | 70866 | 0.030 |
Why?
|
| Suture Techniques | 1 | 1979 | 792 | 0.030 |
Why?
|
| National Cancer Institute (U.S.) | 1 | 2015 | 260 | 0.030 |
Why?
|
| Lung Neoplasms | 2 | 2015 | 12539 | 0.030 |
Why?
|
| Fetal Heart | 1 | 2015 | 273 | 0.030 |
Why?
|
| Middle Cerebral Artery | 1 | 2015 | 282 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 14 | 1 | 2014 | 308 | 0.030 |
Why?
|
| Brain Neoplasms | 1 | 2014 | 8805 | 0.030 |
Why?
|
| Sigmoidoscopes | 1 | 2012 | 6 | 0.030 |
Why?
|
| Ultrasonography, Doppler | 1 | 2015 | 456 | 0.030 |
Why?
|
| Physician-Nurse Relations | 1 | 2012 | 21 | 0.030 |
Why?
|
| Infertility | 1 | 2019 | 580 | 0.030 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2014 | 515 | 0.030 |
Why?
|
| Male | 15 | 2019 | 350324 | 0.030 |
Why?
|
| Postoperative Complications | 3 | 2012 | 15079 | 0.030 |
Why?
|
| Predictive Value of Tests | 2 | 2019 | 15199 | 0.030 |
Why?
|
| Vascular Surgical Procedures | 3 | 1980 | 1451 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2015 | 9596 | 0.030 |
Why?
|
| Iatrogenic Disease | 1 | 2014 | 527 | 0.030 |
Why?
|
| Neurons | 1 | 2011 | 9375 | 0.030 |
Why?
|
| Organizational Innovation | 1 | 2015 | 572 | 0.030 |
Why?
|
| Thumb | 3 | 1984 | 225 | 0.030 |
Why?
|
| Replantation | 2 | 1984 | 149 | 0.030 |
Why?
|
| Retrospective Studies | 6 | 2019 | 72443 | 0.030 |
Why?
|
| Chromosomes, Human, 16-18 | 1 | 1970 | 33 | 0.030 |
Why?
|
| Equipment Contamination | 1 | 2012 | 179 | 0.030 |
Why?
|
| Fetal Growth Retardation | 1 | 2015 | 556 | 0.030 |
Why?
|
| Cutis Laxa | 1 | 1970 | 25 | 0.020 |
Why?
|
| Chromosomes, Human | 1 | 2012 | 475 | 0.020 |
Why?
|
| Autopsy | 1 | 2014 | 988 | 0.020 |
Why?
|
| Fluid Therapy | 1 | 2014 | 608 | 0.020 |
Why?
|
| Patient Selection | 2 | 2015 | 4293 | 0.020 |
Why?
|
| Polyhydramnios | 1 | 2009 | 43 | 0.020 |
Why?
|
| Gestational Age | 2 | 2009 | 3446 | 0.020 |
Why?
|
| Incidence | 3 | 2014 | 20731 | 0.020 |
Why?
|
| Models, Educational | 1 | 2012 | 395 | 0.020 |
Why?
|
| Thoracoscopy | 1 | 2010 | 181 | 0.020 |
Why?
|
| Respiratory Tract Diseases | 1 | 2014 | 715 | 0.020 |
Why?
|
| Models, Organizational | 1 | 2012 | 583 | 0.020 |
Why?
|
| Organ Culture Techniques | 1 | 2011 | 856 | 0.020 |
Why?
|
| Animals | 3 | 2017 | 169420 | 0.020 |
Why?
|
| Sequence Deletion | 1 | 2012 | 1550 | 0.020 |
Why?
|
| Electrophysiology | 1 | 2011 | 1315 | 0.020 |
Why?
|
| Minority Groups | 1 | 2015 | 1088 | 0.020 |
Why?
|
| Glyceraldehyde-3-Phosphate Dehydrogenases | 1 | 2007 | 74 | 0.020 |
Why?
|
| Monosomy | 1 | 2007 | 50 | 0.020 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 2007 | 225 | 0.020 |
Why?
|
| Case-Control Studies | 2 | 2017 | 21797 | 0.020 |
Why?
|
| Severity of Illness Index | 2 | 2017 | 15909 | 0.020 |
Why?
|
| Neoplasms | 1 | 2015 | 20528 | 0.020 |
Why?
|
| Massachusetts | 1 | 2019 | 8743 | 0.020 |
Why?
|
| Middle Aged | 6 | 2017 | 214639 | 0.020 |
Why?
|
| Program Evaluation | 1 | 2015 | 2539 | 0.020 |
Why?
|
| Consensus | 1 | 2015 | 2743 | 0.020 |
Why?
|
| Urine | 1 | 2007 | 381 | 0.020 |
Why?
|
| Sample Size | 1 | 2008 | 823 | 0.020 |
Why?
|
| Cooperative Behavior | 1 | 2012 | 1554 | 0.020 |
Why?
|
| Hemoglobins | 1 | 2010 | 1502 | 0.020 |
Why?
|
| Physician-Patient Relations | 1 | 2017 | 3318 | 0.010 |
Why?
|
| Academic Medical Centers | 1 | 2014 | 2789 | 0.010 |
Why?
|
| Decision Making | 1 | 2017 | 3846 | 0.010 |
Why?
|
| Syndrome | 1 | 2009 | 3193 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 2009 | 3542 | 0.010 |
Why?
|
| Attitude of Health Personnel | 1 | 2017 | 3902 | 0.010 |
Why?
|
| Alleles | 1 | 2014 | 7099 | 0.010 |
Why?
|
| Specimen Handling | 1 | 2007 | 698 | 0.010 |
Why?
|
| Child, Preschool | 6 | 2012 | 41198 | 0.010 |
Why?
|
| Internet | 1 | 2014 | 3079 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2015 | 8075 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 2008 | 2405 | 0.010 |
Why?
|
| Time Factors | 2 | 2012 | 40875 | 0.010 |
Why?
|
| Veins | 1 | 1984 | 745 | 0.010 |
Why?
|
| Amputation, Traumatic | 1 | 1980 | 126 | 0.010 |
Why?
|
| Finger Injuries | 1 | 1980 | 135 | 0.010 |
Why?
|
| Follow-Up Studies | 3 | 2012 | 39300 | 0.010 |
Why?
|
| Cryptorchidism | 1 | 1980 | 123 | 0.010 |
Why?
|
| Genotype | 1 | 2014 | 12919 | 0.010 |
Why?
|
| Research Design | 1 | 2015 | 5902 | 0.010 |
Why?
|
| Femoral Vein | 1 | 1979 | 158 | 0.010 |
Why?
|
| Toes | 1 | 1979 | 196 | 0.010 |
Why?
|
| Laparoscopy | 1 | 2010 | 1980 | 0.010 |
Why?
|
| Patient Compliance | 1 | 2009 | 2744 | 0.010 |
Why?
|
| Adolescent | 5 | 2017 | 85155 | 0.010 |
Why?
|
| Fingers | 1 | 1980 | 515 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2012 | 11145 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2007 | 6274 | 0.010 |
Why?
|
| Testis | 1 | 1980 | 802 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2019 | 40029 | 0.010 |
Why?
|
| Femoral Artery | 1 | 1979 | 844 | 0.010 |
Why?
|
| Survival Rate | 1 | 2009 | 13206 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2014 | 15603 | 0.010 |
Why?
|
| Skin Transplantation | 1 | 1979 | 1119 | 0.010 |
Why?
|
| Graft Survival | 1 | 1984 | 3750 | 0.010 |
Why?
|
| Rabbits | 1 | 1979 | 5061 | 0.010 |
Why?
|
| Internship and Residency | 1 | 2012 | 5623 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2011 | 22665 | 0.010 |
Why?
|
| Infant | 3 | 2010 | 34569 | 0.010 |
Why?
|
| Micrognathism | 1 | 1970 | 49 | 0.010 |
Why?
|
| Genitalia | 1 | 1970 | 101 | 0.010 |
Why?
|
| Aged | 4 | 2012 | 162448 | 0.010 |
Why?
|
| Algorithms | 1 | 2009 | 13758 | 0.010 |
Why?
|
| Child | 4 | 2010 | 74468 | 0.000 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2014 | 34430 | 0.000 |
Why?
|
| Transplantation, Autologous | 2 | 1980 | 2069 | 0.000 |
Why?
|
| Mice | 1 | 2011 | 80375 | 0.000 |
Why?
|
| Treatment Outcome | 1 | 2010 | 62004 | 0.000 |
Why?
|
| Blood Circulation | 1 | 1984 | 253 | 0.000 |
Why?
|
| Pedigree | 1 | 1970 | 4710 | 0.000 |
Why?
|
| Scrotum | 1 | 1980 | 119 | 0.000 |
Why?
|
| Methods | 1 | 1979 | 1160 | 0.000 |
Why?
|
| Follicle Stimulating Hormone | 1 | 1980 | 730 | 0.000 |
Why?
|
| Luteinizing Hormone | 1 | 1980 | 870 | 0.000 |
Why?
|
| Analysis of Variance | 1 | 1984 | 6501 | 0.000 |
Why?
|
| Age Factors | 2 | 1984 | 18784 | 0.000 |
Why?
|
| Testicular Neoplasms | 1 | 1980 | 767 | 0.000 |
Why?
|
| Phenotype | 1 | 1970 | 16311 | 0.000 |
Why?
|
| Thrombosis | 1 | 1984 | 2843 | 0.000 |
Why?
|
| Prognosis | 1 | 1984 | 29005 | 0.000 |
Why?
|
| Prospective Studies | 1 | 1984 | 51315 | 0.000 |
Why?
|